tiprankstipranks
Trending News
More News >
ExpreS2ion Biotech Holding AB (SE:EXPRS2)
:EXPRS2
Sweden Market
Advertisement

ExpreS2ion Biotech Holding AB (EXPRS2) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

EXPRS2 Financial Forecast

EXPRS2 Earnings Forecast

The previous quarter’s earnings for EXPRS2 were -kr4.30.
The previous quarter’s earnings for EXPRS2 were -kr4.30.

EXPRS2 Sales Forecast

The previous quarter’s earnings for EXPRS2 were kr1.33M.
The previous quarter’s earnings for EXPRS2 were kr1.33M.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on SE:EXPRS2
TipRanks AITipRanks
Not Ranked
TipRanks
kr23.5
Hold
-3.69%
Downside
Reiterated
07/19/25
ExpreS2ion Biotech Holding AB's overall stock score is primarily affected by its poor financial performance, characterized by consistent net losses and negative cash flow. Technical analysis provides some neutral to slightly positive signals, but valuation remains weak with a negative P/E ratio. The lack of earnings call data and corporate events means these components did not influence the score.
AI Firm
kr23.5kr22.5
Hold
-7.79%
Downside
Reiterated
06/20/25
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on SE:EXPRS2
TipRanks AITipRanks
Not Ranked
TipRanks
kr23.5
Hold
-3.69%
Downside
Reiterated
07/19/25
ExpreS2ion Biotech Holding AB's overall stock score is primarily affected by its poor financial performance, characterized by consistent net losses and negative cash flow. Technical analysis provides some neutral to slightly positive signals, but valuation remains weak with a negative P/E ratio. The lack of earnings call data and corporate events means these components did not influence the score.
AI Firm
kr23.5kr22.5
Hold
-7.79%
Downside
Reiterated
06/20/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

EXPRS2 Analyst Recommendation Trends

Rating
May 25
Jun 25
Strong Buy
0
0
Buy
0
0
Hold
2
4
Sell
0
0
Strong Sell
0
0
total
2
4
In the current month, EXPRS2 has received 0 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. EXPRS2 average Analyst price target in the past 3 months is 22.47.
Each month's total comprises the sum of three months' worth of ratings.

EXPRS2 Stock Forecast FAQ

What is SE:EXPRS2’s average 12-month price target, according to analysts?
Based on analyst ratings, ExpreS2ion Biotech Holding AB’s 12-month average price target is 22.47.
    What is SE:EXPRS2’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for SE:EXPRS2, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is ExpreS2ion Biotech Holding AB a Buy, Sell or Hold?
        ExpreS2ion Biotech Holding AB has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
          What is ExpreS2ion Biotech Holding AB’s share price target?
          The average share price target for ExpreS2ion Biotech Holding AB is 22.47. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is kr22.47 ,and the lowest forecast is kr22.47. The average share price target represents -7.93% Decrease from the current price of kr24.4.
            What do analysts say about ExpreS2ion Biotech Holding AB?
            ExpreS2ion Biotech Holding AB’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
              How can I buy shares of ExpreS2ion Biotech Holding AB?
              To buy shares of SE:EXPRS2, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis